These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6695637)

  • 1. Rolipram in Parkinson's disease.
    Parkes JD; Thompson C; Brennan L; Gajraj N; Howcroft B; Ruiz J
    Adv Neurol; 1984; 40():563-5. PubMed ID: 6695637
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Parkinson's disease.
    Bergus G
    J Fam Pract; 1996 May; 42(5):457-8. PubMed ID: 8642360
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-O-Methyldopa in Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Adv Neurol; 1974; 5():309-15. PubMed ID: 4440579
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Parkinson's disease with lergotrile mesylate.
    Lieberman A; Estey E; Kupersmith M; Gopinathan G; Goldstein M
    JAMA; 1977 Nov; 238(22):2380-2. PubMed ID: 335094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole therapy for Parkinson's disease.
    Pahwa R; Lyons KE; Hauser RA
    Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of artistic productivity in Parkinson's disease.
    Walker RH; Warwick R; Cercy SP
    Mov Disord; 2006 Feb; 21(2):285-6. PubMed ID: 16261619
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease.
    Djaldetti R; Ziv I; Melamed E
    Isr J Med Sci; 1996 Dec; 32(12):1224-7. PubMed ID: 9007159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological therapy of complicated Parkinson's disease].
    Jiménez-Jiménez FJ; Molina JA
    Rev Neurol; 1997 Aug; 25 Suppl 2():S170-9. PubMed ID: 9280685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary.
    Quinn NP
    J Neurol; 2003 Jan; 250(1):97. PubMed ID: 12528000
    [No Abstract]   [Full Text] [Related]  

  • 11. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for Parkinson's disease.
    Health News; 2000 Jun; 6(6):8. PubMed ID: 10865523
    [No Abstract]   [Full Text] [Related]  

  • 13. Deprenyl in Parkinson's disease.
    Korczyn AD; Nisipeanu P
    Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M; Reichmann H; Riederer P
    Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2003 Dec; (10):1582-98. PubMed ID: 15555162
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages.
    MacMahon DG; Bland R
    BMJ; 1996 Mar; 312(7032):703; author reply 704-5. PubMed ID: 8597748
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used.
    Gerlach M; Riederer P; Vogt H
    BMJ; 1996 Mar; 312(7032):704; author reply 704-5. PubMed ID: 8597750
    [No Abstract]   [Full Text] [Related]  

  • 19. [ What drug strategies are advisable for patients with advanced-stage Parkinson's].
    Brefel-Courbon C
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():120-59. PubMed ID: 10916046
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
    Gerschlager W; Bloem BR
    Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.